Trial intelligence / Profile preview

Effect of pioglitazone on menstrual cyclicity in women with polycystic ovarian syndrome

IRCT2012072810415N1Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pioglitazone in polycystic ovary syndrome (PCOS), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Menstrual cyclicity improvement. Started Nov 2012; status: completed.

02

Drugs

pioglitazone
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on IRCT2012072810415N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2012072810415N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call